MindMaze Therapeutics

Neurones in the brain
#Leadership appointment #MindMaze Therapeutics #Neuroplasticity #Neuroscience #New appointment

MindMaze Therapeutics appoints strategic advisor for US growth

MindMaze Therapeutics has appointed Dr John Krakauer as a strategic advisor to support its next phase of growth in the United States.  “John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery,” said Zach Henderson, CEO of MindMaze Therapeutics. “As… Read More

#News

Neurons
#MindMaze Therapeutics #Neurology #Neuroscience

MindMaze Therapeutics refocuses efforts on neurology

MindMaze Therapeutics has announced the completion of its organisational simplification initiative, and the implementation of its CHF 8 ($9.8) million strategic equity financing with Neuro.io Group.  The company’s organisational simplification initiative included the selling of substantially all remaining non-neurology legacy operations acquired through its business combination with… Read More

#Business & Investment #News